According to some estimates, nearly 2.3 million people in the US suffer from dementia-related psychosis. The Gerontological Society of America’s diagnostic and treatment considerations help shed light on this complicated condition.
According to some estimates, nearly 2.3 million people in the US suffer from dementia-related psychosis (DRP). The Gerontological Society of America’s diagnostic and treatment considerations help shed light on this complicated condition.
Nonetheless, symptoms of DRP impact quality of life for both patients and caregivers. DRP is also predictive of progression to nursing home care as well as higher mortality rates.
These diagnostic criteria have yet to become official and codified. Formal diagnostic criteria for DRP is needed. Not only will this support clinicians in providing appropriate care, but such would assist in coding and documentation.
More specific assessment tools specific to DRP would further assist clinicians in supporting patients and developing effective treatment strategies.
DRP can be difficult for caregivers. Health care teams should provide education and support to caregivers. Similarly, family should know about other options and should consider plans should symptoms worsen.
Similarly, the Substance Abuse and Mental Health Services Administration has also noted a preference for nonpharmacological strategies but that pharmacological options may be warranted if symptoms cause severe distress to the patient or an immediate risk of harm to self or others.
The report is available at https://www.geron.org/images/documents/dementiarelatedpsychosis2019.pdf